Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,388 | 705 | 98.3% |
| Education | $167.19 | 25 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,335 | 99 | $0 (2024) |
| Novo Nordisk Inc | $1,202 | 131 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $834.70 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $787.25 | 34 | $0 (2021) |
| Amarin Pharma Inc. | $697.49 | 74 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $576.89 | 12 | $0 (2018) |
| PFIZER INC. | $506.41 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $348.02 | 34 | $0 (2022) |
| ABBVIE INC. | $345.37 | 22 | $0 (2024) |
| Allergan, Inc. | $318.65 | 30 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $764.74 | 42 | GlaxoSmithKline, LLC. ($383.61) |
| 2023 | $330.67 | 20 | GlaxoSmithKline, LLC. ($73.03) |
| 2022 | $819.73 | 54 | GlaxoSmithKline, LLC. ($192.40) |
| 2021 | $967.97 | 93 | Amarin Pharma Inc. ($197.36) |
| 2020 | $1,162 | 96 | Novo Nordisk Inc ($229.95) |
| 2019 | $1,439 | 115 | Boehringer Ingelheim Pharmaceuticals, Inc. ($352.29) |
| 2018 | $1,630 | 136 | Novo Nordisk Inc ($232.27) |
| 2017 | $2,442 | 174 | Kowa Pharmaceuticals America, Inc. ($492.65) |
All Payment Transactions
730 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: PAIN | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: PAIN | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: PAIN | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PAIN | ||||||
| 06/25/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Elastography | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,603 | 2,907 | $562,840 | $180,310 |
| 2022 | 17 | 1,896 | 3,010 | $601,695 | $206,217 |
| 2021 | 16 | 2,027 | 3,173 | $530,045 | $195,797 |
| 2020 | 15 | 2,055 | 3,181 | $483,845 | $168,111 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 598 | 1,818 | $399,960 | $119,201 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $21,375 | $11,470 | 53.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 120 | 120 | $17,380 | $9,086 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 58 | $18,270 | $6,404 | 35.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 153 | 154 | $9,240 | $5,589 | 60.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $19,080 | $5,292 | 27.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 93 | 100 | $22,000 | $5,228 | 23.8% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 21 | 21 | $14,175 | $4,451 | 31.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,550 | $3,946 | 86.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 35 | 58 | $8,700 | $2,923 | 33.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 200 | 221 | $16,575 | $2,653 | 16.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,800 | $1,295 | 71.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 17 | $2,550 | $722.24 | 28.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $1,140 | $689.51 | 60.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 17 | 17 | $1,020 | $567.47 | 55.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 35 | 38 | $2,850 | $496.50 | 17.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 63 | 87 | $2,175 | $296.67 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 462 | 1,058 | $232,760 | $74,889 | 32.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 434 | 898 | $197,560 | $62,181 | 31.5% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 92 | 92 | $62,100 | $21,693 | 34.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 157 | 157 | $21,195 | $10,901 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 214 | 218 | $13,080 | $7,863 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 50 | $15,750 | $5,678 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $8,550 | $4,622 | 54.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $11,395 | $3,898 | 34.2% |
About Dr. Lorena Tan, MD
Dr. Lorena Tan, MD is a Family Medicine healthcare provider based in Livermore, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417957697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorena Tan, MD has received a total of $9,555 in payments from pharmaceutical and medical device companies, with $764.74 received in 2024. These payments were reported across 730 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($9,388).
As a Medicare-enrolled provider, Tan has provided services to 7,581 Medicare beneficiaries, totaling 12,271 services with total Medicare billing of $750,435. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Livermore, CA
- Active Since 07/28/2005
- Last Updated 11/15/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417957697
Products in Payments
- TRELEGY ELLIPTA (Drug) $808.22
- Ozempic (Drug) $719.66
- Vascepa (Drug) $697.49
- Livalo (Drug) $576.89
- Victoza (Drug) $359.30
- TRADJENTA (Drug) $321.65
- NURTEC ODT (Drug) $301.03
- SYMBICORT (Drug) $252.37
- JANUVIA (Drug) $250.40
- OFEV (Drug) $250.00
- UBRELVY (Drug) $222.57
- FARXIGA (Drug) $194.22
- JARDIANCE (Drug) $192.10
- XARELTO (Drug) $176.84
- QULIPTA (Drug) $142.46
- AREXVY (Drug) $136.61
- BREZTRI (Drug) $134.95
- ELIQUIS (Drug) $126.36
- SHINGRIX (Biological) $121.39
- VRAYLAR (Drug) $115.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Livermore
Tsung Wong, Md, MD
Family Medicine — Payments: $13,382
Mignonette Willkom, Md, MD
Family Medicine — Payments: $427.78
Dr. Richard Kilker, Md, MD
Family Medicine — Payments: $161.48
Alicia Lo, Md, MD
Family Medicine — Payments: $145.79
Dr. Patrick Keller, Md, MD
Family Medicine — Payments: $95.50
Komalpreet Kaur, Md, MD
Family Medicine — Payments: $20.23